Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0000950103-23-003906
Filing Date
2023-03-09
Accepted
2023-03-09 16:48:02
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM F-3 dp190353_f3.htm F-3 351493
2 EXHIBIT 4.3 dp190353_ex0403.htm EX-4.3 350390
3 EXHIBIT 5.1 dp190353_ex0501.htm EX-5.1 31666
4 EXHIBIT 5.2 dp190353_ex0502.htm EX-5.2 16491
5 EXHIBIT 23.1 dp190353_ex2301.htm EX-23.1 2317
6 EXHIBIT 23.2 dp190353_ex2302.htm EX-23.2 2320
7 EXHIBIT 107.1 dp190353_exfilingfees.htm EX-FILING FEES 31708
8 GRAPHIC image_001.jpg GRAPHIC 4428
9 GRAPHIC image_002.jpg GRAPHIC 2376
10 GRAPHIC image_003.jpg GRAPHIC 1532
11 GRAPHIC image_004.jpg GRAPHIC 4750
  Complete submission text file 0000950103-23-003906.txt   805959
Mailing Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95
Business Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95 353 1 437 8334
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-270418 | Film No.: 23720374
SIC: 2834 Pharmaceutical Preparations